A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Early Alzheimer's Disease
Interventions
DRUG

CT1812

Study Drug

DRUG

Placebo

Non-active study drug

Trial Locations (50)

10029

Mount Sinai School of Medicine, New York

10032

Columbia University Medical Center, New York

14620

University of Rochester Medical Center, Rochester

19001

Abington Neurological Associates, Abington

19104

University of Pennsylvania, Philadelphia

20057

Georgetown University, Washington D.C.

20060

Howard University, Washington D.C.

21224

John Hopkins University, Baltimore

27157

Wake Forest University Health Sciences, Winston-Salem

29401

Ralph H. Johnson VA MC, Charleston

32216

Mayo Clinic,Jacksonville, Jacksonville

32751

K2 Medical Research, LLC, Maitland

32789

Conquest Research, LLC, Winter Park

32803

Charter Research, Orlando

32819

Headlands Research Orlando, Orlando

33135

Advanced Clinical Research Network, Corp, Miami

33445

Brain Matters Research, Delray Beach

33462

JEM Research Institute, Lake Worth

33613

University of South Florida, Tampa

33912

Neuropsychiatric Research Center of Southwest Florida, Fort Myers

34997

Brain Matters Research Stuart, Stuart

35294

University of Alabama at Birmingham, Birmingham

37212

Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville

37232

Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville

40504

Sanders-Brown Center on Aging, Lexington

43210

Ohio State University, Columbus

44122

Case Western Reserve University / University Hospitals, Beachwood

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor, Ann Arbor

53726

University of Wisconsin, Madison

55901

Mayo Clinic, Rochester, Rochester

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

74136

Central States Research, LLC, Tulsa

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

Houston Methodist Neurological Institute, Houston

78229

University of Texas Health Science Center, San Antonio

85006

Banner Alzheimer's Institute, Phoenix

85351

Banner Sun Health Research Institute, Sun City

89106

Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

92697

University of California, Irvine

94304

Stanford University, Palo Alto

95816

Sutter Institute for Medical Research, Sacramento

97210

Summit Headlands LLC, Portland

97239

Oregon Health & Science University, Portland

06510

Yale University, New Haven

02115

Brigham and Women's Hospital, Boston

02360

Highlands Research Eastern MA, Plymouth

02906

Butler Hospital, Providence

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Alzheimer's Clinical Trials Consortium

OTHER

lead

Cognition Therapeutics

INDUSTRY

NCT05531656 - A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter